Ono Pharmaceutical Co., Ltd. (OPHLY)
5.09
-0.02
(-0.39%)
USD |
OTCM |
Aug 24, 16:00
Ono Pharmaceutical Debt to Equity Ratio : 0.1351 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1351 |
| March 31, 2026 | 0.1422 |
| December 31, 2025 | 0.1482 |
| September 30, 2025 | 0.1617 |
| June 30, 2025 | 0.1788 |
| March 31, 2025 | 0.1875 |
| December 31, 2024 | 0.1891 |
| September 30, 2024 | 0.2066 |
| June 30, 2024 | 0.2006 |
| March 31, 2024 | 0.0112 |
| December 31, 2023 | 0.0109 |
| September 30, 2023 | 0.0115 |
| June 30, 2023 | 0.0123 |
| March 31, 2023 | 0.0124 |
| December 31, 2022 | 0.0123 |
| September 30, 2022 | 0.0118 |
| June 30, 2022 | 0.0129 |
| March 31, 2022 | 0.0134 |
| December 31, 2021 | 0.0138 |
| September 30, 2021 | 0.0133 |
| June 30, 2021 | 0.0137 |
| March 31, 2021 | 0.0143 |
| December 31, 2020 | 0.0145 |
| September 30, 2020 | 0.0154 |
| June 30, 2020 | 0.0135 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0149 |
| December 31, 2019 | 0.0157 |
| September 30, 2019 | 0.016 |
| June 30, 2019 | 0.0152 |
| March 31, 2019 | 0.0039 |
| December 31, 2018 | 0.0041 |
| September 30, 2018 | 0.0015 |
| June 30, 2018 | 0.0012 |
| March 31, 2018 | 0.0014 |
| December 31, 2017 | 0.0014 |
| September 30, 2017 | 0.0016 |
| June 30, 2017 | 0.0018 |
| March 31, 2017 | 0.0019 |
| December 31, 2016 | 0.0021 |
| September 30, 2016 | 0.0021 |
| June 30, 2016 | 0.0019 |
| March 31, 2016 | 0.0018 |
| December 31, 2015 | 0.0018 |
| September 30, 2015 | 0.0016 |
| June 30, 2015 | 0.0013 |
| March 31, 2015 | 0.0013 |
| December 31, 2014 | 0.0014 |
| September 30, 2014 | 0.0018 |
| June 30, 2014 | 0.002 |
| March 31, 2014 | 0.0022 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.6536 |
| Daiichi Sankyo Co., Ltd. | 0.2939 |
| Astellas Pharma, Inc. | 0.3036 |
| Eisai Co., Ltd. | 0.2993 |
| Chugai Pharmaceutical Co., Ltd. | 0.0087 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.672B |
| Total Liabilities (Quarterly) | 1.302B |
| Shareholders Equity (Quarterly) | 5.334B |
| Current Ratio | 3.283 |
| Net Debt Paydown Yield | 0.76% |